春立医疗
(688236)
| 流通市值：82.95亿 | | | 总市值：110.31亿 |
| 流通股本：2.88亿 | | | 总股本：3.84亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 756,093,897.4 | 487,596,405.66 | 229,843,941.53 | 805,857,022.19 |
| 营业收入 | 756,093,897.4 | 487,596,405.66 | 229,843,941.53 | 805,857,022.19 |
| 二、营业总成本 | 515,865,735.32 | 333,777,775.81 | 163,972,970.3 | 678,243,060.18 |
| 营业成本 | 247,450,780.09 | 160,472,617.89 | 76,572,465.53 | 268,952,851.12 |
| 税金及附加 | 6,867,479.82 | 4,531,943.83 | 1,960,604.51 | 7,723,578.58 |
| 销售费用 | 146,195,182.01 | 96,267,759.62 | 46,121,370.37 | 240,247,102.81 |
| 管理费用 | 38,603,081.68 | 28,394,457.44 | 16,587,602.35 | 45,290,473.71 |
| 研发费用 | 86,472,598.27 | 50,854,271.53 | 26,897,460.32 | 133,096,848.59 |
| 财务费用 | -9,723,386.55 | -6,743,274.5 | -4,166,532.78 | -17,067,794.63 |
| 其中:利息费用 | 14,188.8 | 12,292.7 | - | 44,939.07 |
| 其中:利息收入 | 10,658,846.31 | 7,674,348.71 | 4,176,613.37 | 16,309,711.03 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | 7,078,936.97 | 4,296,252.04 | 1,604,306.84 | 9,434,830.14 |
| 加:投资收益 | 3,217,026.86 | 3,217,026.86 | 3,217,026.86 | 10,980,482.17 |
| 资产处置收益 | 3,848.03 | 3,848.03 | -15,716.81 | 39,213.61 |
| 资产减值损失(新) | -32,062,823.41 | -26,911,765.98 | -790,286.65 | -33,776,793.41 |
| 信用减值损失(新) | -13,646,674.5 | -12,418,491.12 | -7,583,337.28 | -4,186,610.52 |
| 其他收益 | 6,909,455.54 | 5,307,719.73 | 2,183,975.41 | 20,609,609.96 |
| 四、营业利润 | 211,727,931.57 | 127,313,219.41 | 64,486,939.6 | 130,714,693.96 |
| 加:营业外收入 | 195,880.52 | 0.84 | 0.04 | 987,389.36 |
| 减:营业外支出 | 135,115.14 | 700 | - | 102,914.25 |
| 五、利润总额 | 211,788,696.95 | 127,312,520.25 | 64,486,939.64 | 131,599,169.07 |
| 减:所得税费用 | 20,176,273.09 | 12,831,365.21 | 6,456,361.94 | 6,937,885.57 |
| 六、净利润 | 191,612,423.86 | 114,481,155.04 | 58,030,577.7 | 124,661,283.5 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 191,612,423.86 | 114,481,155.04 | 58,030,577.7 | 124,661,283.5 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 191,531,404.47 | 114,469,490.87 | 58,071,117.89 | 124,988,009.59 |
| 少数股东损益 | 81,019.39 | 11,664.17 | -40,540.19 | -326,726.09 |
| 扣除非经常损益后的净利润 | 180,704,056.22 | 106,185,458.23 | 52,698,123.38 | 94,536,002.4 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.5 | 0.3 | 0.15 | 0.33 |
| (二)稀释每股收益 | 0.5 | 0.3 | 0.15 | 0.33 |
| 九、综合收益总额 | 191,612,423.86 | 114,481,155.04 | 58,030,577.7 | 124,661,283.5 |
| 归属于母公司股东的综合收益总额 | 191,531,404.47 | 114,469,490.87 | 58,071,117.89 | 124,988,009.59 |
| 归属于少数股东的综合收益总额 | 81,019.39 | 11,664.17 | -40,540.19 | -326,726.09 |
| 公告日期 | 2025-10-31 | 2025-08-30 | 2025-04-30 | 2025-03-29 |
| 审计意见(境内) | | | | 标准无保留意见 |